How good is Steven Rosenberg?

Steven Rosenberg has a Lunoo score of 9.4/10. This score is based on AI-powered analysis of category fit, feature coverage, pricing signals, public reception, and recency.

Where does Steven Rosenberg rank on Lunoo?

Steven Rosenberg is ranked #26 in Lunoo's Best Surgeon rankings with a score of 9.4/10.

What are the best alternatives to Steven Rosenberg?

Visit lunoo.com/alternatives/steven-rosenberg to see top-ranked competitors with objective AI-powered scores and side-by-side comparisons.

zoom_in Click to enlarge

Steven Rosenberg

9.40

Excellent

▲ ▼

Surgeon Modern Immunotherapy Surgical Oncology Nci

description Steven Rosenberg Overview

Steven Rosenberg is a prominent surgical oncologist specializing in immunotherapy’s application within cancer treatment. His research at the National Cancer Institute has significantly advanced understanding of how the immune system can be harnessed to combat tumors. He focuses on developing and refining techniques for patients with advanced cancers, particularly those seeking innovative approaches beyond traditional surgery.

help Steven Rosenberg FAQ

What type of cancer treatment is Steven Rosenberg known for developing?

Dr. Steven A. Rosenberg is renowned for pioneering the development of immunotherapy, specifically adoptive cell transfer (ACT), to treat cancer. His work heavily focuses on using genetically modified lymphocytes, such as tumor-infiltrating lymphocytes (TILs), to attack tumors. He serves as the chief of surgery at the National Cancer Institute (NCI).

Where does Steven Rosenberg conduct his clinical trials?

Rosenberg conducts his cutting-edge surgical oncology and immunotherapy research at the National Cancer Institute (NCI) in Bethesda, Maryland. He has been a leading researcher there for decades, treating patients with advanced metastatic cancers who have exhausted standard treatments. The NCI provides the resources for his extensive laboratory and clinical investigations.

What is TIL therapy in relation to Rosenberg's work?

Tumor-infiltrating lymphocyte (TIL) therapy is an experimental immunotherapy treatment that Rosenberg championed to treat advanced melanoma and other solid tumors. The process involves extracting immune cells from a patient's tumor, expanding them in a lab, and reinfusing them into the patient. His clinical trials have successfully put many patients with late-stage cancers into long-term remission.

Has Steven Rosenberg authored any major medical textbooks?

Yes, Dr. Rosenberg is the author and editor of cancer: Principles & Practice of Oncology, which is one of the most authoritative and widely used oncology textbooks in the world. Co-authored with Vincent DeVita and others, the text serves as a foundational resource for oncologists globally. His contributions to medical literature parallel his groundbreaking clinical achievements.